Study of Mental Care in Spain
Completed
- Conditions
- Schizophrenia
- Registration Number
- NCT00824031
- Lead Sponsor
- AstraZeneca
- Brief Summary
Non-interventional, multicenter, cross-sectional study to evaluate the mental care received by schizophrenic patients and their caregivers in Spain irrespective of the drug prescribed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
- Schizophrenia (DSM-IV criteria)
- Attended to the mental care units for the first time in 2006
Exclusion Criteria
- Participation in another clinical trial
- Other criteria that according to the medical criteria make difficult the normal development of the study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Camberwell's scale of Needs Analysis (CAN) Once Caregiver Needs Questionnaire(CNF) Once
- Secondary Outcome Measures
Name Time Method Health of the Nation Outcome Scales (HoNOS) Once
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie schizophrenia treatment outcomes in the NCT00824031 observational study?
How does caregiver support in Spain affect adherence to antipsychotic therapies for schizophrenia patients?
What biomarkers correlate with improved mental health outcomes in schizophrenia according to the AstraZeneca Spain study?
Are there adverse events associated with current antipsychotic regimens in the NCT00824031 observational trial?
What insights does the NCT00824031 study provide on comparative effectiveness of atypical vs. typical antipsychotics in Spanish schizophrenia care?
Trial Locations
- Locations (1)
Research Site
🇪🇸Madrid, Spain
Research Site🇪🇸Madrid, Spain